Press Release

Press Release | Feb 24, 2021

Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace Biosciences” or the “Company”), an emerging leader in enabling personalized medicine, today announced that on February 24, 2021, the Company satisfied the requirements for trading of the Company’s common stock on the OTCQX® Best Market (“OTCQX”) and will begin trading on OTCQX at the open of the market on February

Press Release | Feb 18, 2021

Restorative Therapies, Inc – the leading provider of innovative, integrated therapeutic medical devices that are the standard of care in rehabilitation therapy for many neurological conditions – announced today the launch of Xcite2. Xcite2 was designed to allow clinicians to easily and efficiently apply multi-channel FES with task specific activities commonly completed in therapy. The device

Press Release | Feb 15, 2021

Verogen Inc. announced today that it is expanding capabilities for the NDIS-approved MiSeq FGx Sequencing System with the commercial launch of the ForenSeq Kintelligence Kit, a solution optimized for low input and degraded samples. The kit targets 10,230 forensically curated SNPs, alleviating genetic privacy concerns by minimizing medically informative markers. The seamless integration of this workflow

Press Release | Jan 15, 2021

reenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) announced today that Mr. Stephan Roker has provided notice of his intention to resign as a director of the Company, effective today, citing the existence of previously unforeseen conflicts of interest as the reason for his resignation.

Press Release | Jan 12, 2021

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that its shareholders have approved a special resolution for an amendment to the Company’s articles and has authorized a consolidation (the “Share Consolidation”) of the Company’s outstanding common shares (“Common Shares”). The resolution was approved at the special meeting of shareholders held

Press Release | Dec 31, 2020

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it and its subsidiaries have entered into a credit and security agreement for a US$30 million secured credit facility (the “Credit Facility”) with Oxford Finance LLC (“Oxford”).

Press Release | Dec 21, 2020

Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology.  The product, used in complex tumor and orthopaedic reconstructive procedures, is the first FDA cleared, 3D printed limb salvage

Press Release | Dec 18, 2020

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that the second largest U.S. Commercial payer will now cover TheraSkin for all lower extremity dermal wounds. TheraSkin is a proven cellular and tissue-based treatment for difficult to heal chronic wounds.

Press Release | Dec 14, 2020

Aktana, the pioneer in AI-driven intelligent engagement for the life sciences industry, announced major milestones of 2020, including key executive hires, expanded customer partnerships, and the launch of its next-generation Contextual Intelligence Engine. Aktana’s growth reflects increasing demand for AI capabilities to enable more effective multichannel customer engagement in life sciences, as evidenced by their nearly

Press Release | Dec 10, 2020

Innovative Health, Inc. today announced it has received the first-ever U.S. patent for a microlumen reprocessing technology, a milestone in ensuring patient safety while advancing the vital discipline of reprocessing single-use cardiology medical devices. The patent (US Patent 10,830,682), which covers a novel test method for identifying subvisible occluding particles in microlumens, grants Innovative Health a

Press Release | Dec 02, 2020

TRIMEDX, an industry-leading provider of clinical engineering, medical device cybersecurity and clinical asset management solutions to healthcare providers, announced the acquisition of Centurion Service Group, a full-service surplus medical equipment management company, to expand its Clinical Asset Management offering. The added capabilities of Centurion will allow TRIMEDX clients to gain maximum value from their excess medical

Press Release | Nov 25, 2020

Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December 31, 2020. He will be replaced as President and Chief Executive Officer by Thomas Burnell, PhD., effective December 1, 2020. Mr. Stover, who will step down from the Interpace Board of Directors once Dr. Burnell joins

Pages 1 2 3 4 5 6 12